Table 4.
Patient outcomes post-matching
| Outcome | COVID + (n = 736) | COVID – (n = 736) | Odds ratio (OR) | Confidence Interval (CI) | P |
|---|---|---|---|---|---|
| Mortality, % (n) | 1.6 (12) | 1.4 (10) | 1.203 | 0.517–2.803 | 0.6675 |
| Infection, % (n) | 45.4 (334) | 19.0 (140) | 3.537 | 2.798–4.471 | 0.0001 |
| Sepsis, % (n) | 5.4 (40) | 2.7 (20) | 2.057 | 1.191–3.555 | 0.0084 |
| Pseudomonas infection, % (n) | 1.4 (10) | 1.4 (10) | — | — | 1 |
| MRSA infection, % (n) | 3.4 (25) | 1.4 (10) | 2.553 | 1.217–5.354 | 0.0103 |
| Pneumonia, % (n) | 8.3 (61) | 5.4 (40) | 1.572 | 1.041–2.376 | 0.0304 |
| Respiratory failure, % (n) | 6.8 (50) | 4.2 (31) | 1.658 | 1.046–2.626 | 0.0299 |
| Acute respiratory distress syndrome, % (n) | 1.4 (10) | 1.4 (10) | — | — | 1 |
| Acute kidney injury, % (n) | 5.2 (38) | 4.6 (34) | 1.124 | 0.699–1.806 | 0.6288 |
| Heart failure, % (n) | 1.8 (13) | 1.4 (10) | 1.32 | 0.575–3.031 | 0.5118 |
| Hepatic failure, % (n) | 1.4 (10) | 1.4 (10) | — | — | 1 |
| Thrombosis (deep vein, arterial, pulmonary embolism), % (n) | 5.8 (43) | 2.6 (19) | 2.342 | 1.351–4.058 | 0.0018 |
| Thrombosis (deep vein), % (n) | 4.5 (33) | 1.6 (12) | 2.832 | 1.451–5.528 | 0.0015 |
| Thrombosis (arterial), % (n) | 1.4 (10) | 1.4 (10) | — | — | 1 |
| Thrombosis (pulmonary embolism), % (n) | 1.8 (13) | 1.4 (10) | 1.305 | 0.569–2.996 | 0.5284 |
| Hypertrophic scarring, % (n) | 16.6 (122) | 5.6 (41) | 3.368 | 2.326–4.877 | 0.0001 |